Sedana Medical AB (7D2A) AI Stock Analysis

0 Followers

Sedana Medical AB

(Frankfurt:7D2A)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong Revenue GrowthRevenue growth of approximately 152% indicates rapidly expanding commercial adoption and market reach. If sustained, this scale can improve operating leverage, support broader ICU penetration, and strengthen the company’s ability to build a durable recurring demand base for devices and anesthetic products.

Negative Factors

Persistent UnprofitabilitySedana has not yet converted strong revenue growth and gross margins into sustainable operating or net profitability. Continued losses can constrain internal funding, require further efficiency improvements, and delay the point at which expanding sales translate into durable shareholder returns.

Sedana Medical AB (7D2A) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 86.41M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -26.4
Beta (1Y): 1.39
Revenue Growth: 3.23%
EPS Growth: 14.32%
Country: Germany
Employees: 117
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Sedana Medical AB Business Overview & Revenue Model

Company Description

Sedana Medical AB (publ) is a medical technology firm that engineers, promotes, and distributes healthcare devices both within Sweden and across global markets. Its product portfolio includes the Sedaconda ACD-L and Sedaconda ACD, single-use medical...

Sedana Medical AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:7D2A against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:GETI.B	67Neutral	SEK 73.87B	26.69	9.13%	1.71%	-3.90%	37.73%
SE:XVIVO	64Neutral	SEK 6.43B	50.37	5.89%	―	17.83%	330.94%
SE:SEZI	55Neutral	SEK 554.97M	-6.04	-35.44%	―	18.56%	28.11%
SE:BACTI.B	53Neutral	SEK 544.93M	85.56	1.93%	―	-0.51%	―
SE:BRAIN	53Neutral	SEK 429.63M	-9.65	-22.23%	―	6.49%	25.03%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

DE:7D2A and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:7D2A	Sedana Medical AB	0.82	-0.01	-1.44%
SE:GETI.B	Getinge AB (UK)	277.30	62.87	29.32%
SE:SEZI	Senzime AB	3.75	-1.58	-29.61%
SE:XVIVO	Xvivo Perfusion AB	206.00	39.60	23.80%
SE:BACTI.B	Bactiguard Holding AB	15.40	-1.30	-7.78%
SE:BRAIN	BrainCool AB	1.12	0.58	105.12%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Sedana Medical AB AI Stock Analysis